These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 19251278)

  • 21. Prostate biopsy interpretation. Current concepts, 1999.
    Iczkowski KA; Bostwick DG
    Urol Clin North Am; 1999 Aug; 26(3):435-52. PubMed ID: 10494283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognosis and predictive factors in prostate cancer].
    Albiges-Sauvin L; Lévy A; Massard C; Fizazi K
    Bull Cancer; 2009 Apr; 96(4):439-49. PubMed ID: 19357018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A framework for the identification of men at increased risk for prostate cancer.
    Roobol MJ; Schröder FH; Crawford ED; Freedland SJ; Sartor AO; Fleshner N; Andriole GL
    J Urol; 2009 Nov; 182(5):2112-20. PubMed ID: 19758625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer.
    Schröder FH; Roobol MJ
    Curr Opin Urol; 2009 May; 19(3):227-31. PubMed ID: 19357513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prostate gland-transition zone lesions. Etiology, growth regulation, growth factors, genetic changes].
    Pavelić J; Zeljko Z
    Lijec Vjesn; 2002; 124(6-7):211-9. PubMed ID: 19658339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rare malignant tumours of the prostate].
    Mazerolles C; Chevreau C
    Bull Cancer; 2007 Jul; 94(7 Suppl):F44-9. PubMed ID: 17845993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re: Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies: R. Abouassaly, N. Tan, A. Moussa and J. S. Jones J Urol 2008; 180: 911-914.
    Feldstein MS; Hentz JG
    J Urol; 2009 Apr; 181(4):1960-1; author reply 1961. PubMed ID: 19251278
    [No Abstract]   [Full Text] [Related]  

  • 28. Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy").
    Montironi R; Scattoni V; Mazzucchelli R; Lopez-Beltran A; Bostwick DG; Montorsi F
    Eur Urol; 2006 Oct; 50(4):666-74. PubMed ID: 16930809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saturation biopsy for detecting and characterizing prostate cancer.
    Jones JS
    BJU Int; 2007 Jun; 99(6):1340-4. PubMed ID: 17428241
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostate carcinoma II: prognostic factors in prostate needle biopsies.
    Montironi R; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Mikuz G; Algaba F; Boccon-Gibod L
    BJU Int; 2006 Mar; 97(3):492-7. PubMed ID: 16469014
    [No Abstract]   [Full Text] [Related]  

  • 31. Intraductal carcinoma of the prostate: a distinct histopathological entity with important prognostic implications.
    Henry PC; Evans AJ
    J Clin Pathol; 2009 Jul; 62(7):579-83. PubMed ID: 19246509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.